February 10, 2017 · STOCK Act disclosure
Representative Debbie Wasserman Schultz (Democrat-FL) bought Keryx Biopharmaceuticals, Inc., a stock transaction, valued at $1,001 - $15,000. The trade took place on February 10, 2017 and was disclosed on February 15, 2017 (owner: DC). Members of Congress must report such transactions within 45 days under the STOCK Act.